TRISCEND II 1-Year Outcomes (primary results at TCT)
Hahn, Rebecca
( COLUMBIA UNIVERSITY
, New York
, New York
, United States
)
Thourani, Vinod
( Piedmont Heart Institute
, Atlanta
, Georgia
, United States
)
Kodali, Susheel
( Columbia University Medical Center
, New York
, New York
, United States
)
Author Disclosures:
Rebecca Hahn:DO have relevant financial relationships
;
Speaker:Boston Scientific:Active (exists now)
; Speaker:Philips Healthcare:Active (exists now)
; Speaker:Edwards Lifescience:Active (exists now)
| Vinod Thourani:DO have relevant financial relationships
;
Ownership Interest:Dasi Simulation:Active (exists now)
; Researcher:croivalve:Active (exists now)
; Researcher:trisol:Active (exists now)
; Researcher:jenavalve:Active (exists now)
; Researcher:innovalve:Active (exists now)
; Researcher:highlife:Active (exists now)
; Researcher:medtronic:Active (exists now)
; Other (please indicate in the box next to the company name):edwards lifesciences: research, advisor:Active (exists now)
; Other (please indicate in the box next to the company name):atricure: research, advisor:Active (exists now)
; Other (please indicate in the box next to the company name):abbott vascular: research, advisor:Active (exists now)
; Other (please indicate in the box next to the company name):artivion: research, advisor:Active (exists now)
| Susheel Kodali:No Answer